Garlic and Cardiovascular Disease: A Critical Review
Open Access
- 1 March 2006
- journal article
- review article
- Published by Elsevier in Journal of Nutrition
- Vol. 136 (3), 736S-740S
- https://doi.org/10.1093/jn/136.3.736s
Abstract
Epidemiologic studies show an inverse correlation between garlic consumption and progression of cardiovascular disease. Cardiovascular disease is associated with multiple factors such as raised serum total cholesterol, raised LDL and an increase in LDL oxidation, increased platelet aggregation, hypertension, and smoking. Numerous in vitro studies have confirmed the ability of garlic to reduce these parameters. Thus, garlic has been shown to inhibit enzymes involved in lipid synthesis, decrease platelet aggregation, prevent lipid peroxidation of oxidized erythrocytes and LDL, increase antioxidant status, and inhibit angiotension-converting enzyme. These findings have also been addressed in clinical trials. The studies point to the fact that garlic reduces cholesterol, inhibits platelet aggregation, reduces blood pressure, and increases antioxidant status. Since 1993, 44% of clinical trials have indicated a reduction in total cholesterol, and the most profound effect has been observed in garlic's ability to reduce the ability of platelets to aggregate. Mixed results have been obtained in the area of blood pressure and oxidative-stress reduction. The findings are limited because very few trials have addressed these issues. The negative results obtained in some clinical trials may also have resulted from usage of different garlic preparations, unknown active constituents and their bioavalability, inadequate randomization, selection of inappropriate subjects, and short duration of trials. This review analyzes in vitro and in vivo studies published since 1993 and concludes that although garlic appears to hold promise in reducing parameters associated with cardiovascular disease, more in-depth and appropriate studies are required.Keywords
This publication has 44 references indexed in Scilit:
- Modulatory influence of sodium 2-propenyl thiosulfate from garlic on cyclooxygenase activity in canine platelets: Possible mechanism for the anti-aggregatory effectProstaglandins, Leukotrienes & Essential Fatty Acids, 2005
- Fruit, Vegetable, and Antioxidant Intake and All-Cause, Cancer, and Cardiovascular Disease Mortality in a Community-dwelling Population in Washington County, MarylandAmerican Journal of Epidemiology, 2004
- Fruit and Vegetable Intake and Risk of Major Chronic DiseaseJNCI Journal of the National Cancer Institute, 2004
- Inhibition of baboon platelet aggregation in vitro and in vivo by the garlic derivative, ajoeneXenotransplantation, 2003
- Garlic as an antioxidant: the good, the bad and the uglyPhytotherapy Research, 2003
- Garlic Compounds Minimize Intracellular Oxidative Stress and Inhibit Nuclear Factor-κB ActivationJournal of Nutrition, 2001
- Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunctionMolecular Aspects of Medicine, 2000
- Garlic reduces plasma lipids by inhibiting hepatic cholesterol and triacylglycerol synthesisLipids, 1994
- Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytesLipids, 1993
- Comparative Pharmacological Investigations ofAllium ursinumandAllium sativumPlanta Medica, 1992